An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings
Clinical trial NCT05362149 · COMPLETED
Trial details
- NCT number
- NCT05362149
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-04
- Primary completion
- 2023-06-30
- Enrollment
- 870
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.